日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors

针对晚期实体瘤患者的BCL2靶向脱氧核糖核酸抑制剂(DNAi)PNT2258的1期研究

Tolcher, Anthony W; Rodrigueza, Wendi V; Rasco, Drew W; Patnaik, Amita; Papadopoulos, Kyriakos P; Amaya, Alex; Moore, Timothy D; Gaylor, Shari K; Bisgaier, Charles L; Sooch, Mina P; Woolliscroft, Michael J; Messmann, Richard A

Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments

更正:利用药代动力学指导的剂量调整来控制甲氨蝶呤的疗程间暴露量

Rodrigueza, Wendi V; Woolliscroft, Michael J; Ebrahim, Abdul-Shukkur; Forgey, Robert; McGovren, Patrick J; Endert, Gerold; Wagner, Andreas; Holewa, Danielle; Aboukameel, Amro; Gill, Richard D; Bisgaier, Charles L; Messmann, Richard A; Whitehead, Christopher E; Izbicka, Elzbieta; Streeper, Robert; Wick, Michael C; Stiegler, Gabriela; Stein, C A; Monsma, David; Webb, Craig; Sooch, Mina P; Panzner, Steffen; Mohammad, Ramzi; Goodwin, Neal C; Al-Katib, Ayad; Pauley, Jennifer L; Panetta, John C; Crews, Kristine R; Pei, Deqing; Cheng, Cheng; McCormick, John; Howard, Scott C; Sandlund, John T; Jeha, Sima; Ribeiro, Raul; Rubnitz, Jeffrey; Pui, Ching-Hon; Evans, William E; Relling, Mary V

Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol

重塑与穿梭。不同受体颗粒在细胞胆固醇动员中协同作用的机制

Rodrigueza, W V; Williams, K J; Rothblat, G H; Phillips, M C